Effective TME-related signature to predict prognosis of patients with head and neck squamous cell carcinoma

被引:0
作者
Wan, Lingfei [1 ,2 ]
Li, Yuanshuai [1 ]
Pan, Wenting [1 ,2 ]
Yong, Yuting [1 ,2 ]
Yang, Chao [3 ]
Li, Chen [1 ]
Zhao, Xingxing [1 ,2 ]
Li, Ruihong [1 ]
Yue, Wen [2 ,4 ]
Yan, Xinlong [1 ]
机构
[1] Beijing Univ Technol, Coll Life Sci & Bioengn, Fac Environm & Life Sci, Beijing, Peoples R China
[2] Beijing Inst Radiat Med, Stem Cell & Regenerat Med Lab, Beijing, Peoples R China
[3] PLA Rocket Force Characterist Med Ctr, Dept Nucleus Radiat Related Injury Treatment, Beijing, Peoples R China
[4] South China Res Ctr Stem Cell & Regenerat Med, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
head and neck squamous cell carcinoma; tumor microenvironment; immune infiltration; tumor mutation burden; prognosis; nomogram; COPY NUMBER VARIATION; GENE; IMMUNOTHERAPY; POLYMORPHISM; RISK;
D O I
10.3389/fmolb.2023.1232875
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: The tumor microenvironment (TME) is crucial for the development of head and neck squamous cell carcinoma (HNSCC). However, the correlation of the characteristics of the TME and the prognosis of patients with HNSCC remains less known.Methods: In this study, we calculated the immune and stromal cell scores using the "estimate" R package. Kaplan-Meier survival and CIBERSORT algorithm analyses were applied in this study.Results: We identified seven new markers: FCGR3B, IGHV3-64, AC023449.2, IGKV1D-8, FCGR2A, WDFY4, and HBQ1. Subsequently, a risk model was constructed and all HNSCC samples were grouped into low- and high-risk groups. The results of both the Kaplan-Meier survival and receiver operating characteristic curve (ROC) analyses showed that the prognosis indicated by the model was accurate (0.758, 0.756, and 0.666 for 1-, 3- and 5-year survival rates). In addition, we applied the CIBERSORT algorithm to reveal the significant differences in the infiltration levels of immune cells between the two risk groups.Discussion: Our study elucidated the roles of the TME and identified new prognostic biomarkers for patients with HNSCC.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] A novel metabolic-related gene signature for predicting clinical prognosis and immune microenvironment in head and neck squamous cell carcinoma
    Cao, Yongxin
    Dai, Zili
    Xie, Guofeng
    Liu, Guihong
    Guo, Liyi
    Zhang, Jian
    [J]. EXPERIMENTAL CELL RESEARCH, 2023, 428 (02)
  • [32] Development of an endoplasmic reticulum stress-related signature with potential implications in prognosis and immunotherapy in head and neck squamous cell carcinoma
    Fan, Xinlong
    Yang, Xiao
    Guo, Nan
    Gao, Xin
    Zhao, Yuejiao
    [J]. DIAGNOSTIC PATHOLOGY, 2023, 18 (01)
  • [33] A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma
    Zhu, Wenying
    Ye, Zhipeng
    Chen, Ling
    Liang, Haifeng
    Cai, Qian
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [34] An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma
    Chen, Dayang
    Wang, Mengmeng
    Guo, Ying
    Wu, Wei
    Ji, Xiang
    Dou, Xiaowen
    Tang, Huamei
    Zong, Zengyan
    Zhang, Xiuming
    Xiong, Dan
    [J]. CANCER MEDICINE, 2021, 10 (17): : 5936 - 5947
  • [35] Development and validation of a hypoxia-related gene pair signature to predict overall survival in head and neck squamous cell carcinoma
    Ding, Zhao
    Li, Hefeng
    Yu, Deshun
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2021, 278 (10) : 3973 - 3983
  • [36] An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma
    Chen, Yue
    Luo, Tian-Qi
    Xu, Si-Si
    Chen, Chun-Yan
    Sun, Ying
    Lin, Li
    Mao, Yan-Ping
    [J]. CANCER MEDICINE, 2021, 10 (07): : 2268 - 2285
  • [37] Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma
    Liu, Guohong
    Yuan, Chunjue
    Ma, Jiaojiao
    Pan, Yunbao
    Xu, Haibo
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous Cell Carcinoma
    Sun, Jing
    Fang, Guiqing
    Zuo, Zhibin
    Yu, Xijiao
    Xue, Lande
    Li, Chong
    Li, Shu
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [39] Mast cell marker gene signature in head and neck squamous cell carcinoma
    Zhimou Cai
    Bingjie Tang
    Lin Chen
    Wenbin Lei
    [J]. BMC Cancer, 22
  • [40] Mast cell marker gene signature in head and neck squamous cell carcinoma
    Cai, Zhimou
    Tang, Bingjie
    Chen, Lin
    Lei, Wenbin
    [J]. BMC CANCER, 2022, 22 (01)